---
title: "Jinhe Biotechnology established a new company, including cell technology research and development business"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253407827.md"
description: "According to the Qichacha APP, recently, Jinhe Aichongyi Biotechnology Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: medical research and experimental development; research and application of cell technology; internet information services for pharmaceuticals, etc. Qichacha's equity penetration shows that the company is wholly owned by Jinhe Biotechnology"
datetime: "2025-08-18T07:24:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253407827.md)
  - [en](https://longbridge.com/en/news/253407827.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253407827.md)
---

# Jinhe Biotechnology established a new company, including cell technology research and development business

According to the Qichacha APP, recently, Jinhe Aichongyi Biotechnology Co., Ltd. was established with a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; research and application of cell technology; internet information services for pharmaceuticals, etc. Qichacha's equity penetration shows that the company is wholly owned by Jinhe Biotechnology

### Related Stocks

- [002688.CN](https://longbridge.com/en/quote/002688.CN.md)

## Related News & Research

- [03:00 ETHuion lanza la libreta electrónica Huion Note E: Productividad accesible para empresas y creativos](https://longbridge.com/en/news/287020642.md)
- [Cantonese restaurant Wing Seong Fatty’s to end 100-year run](https://longbridge.com/en/news/286856179.md)
- [Fast Fashion Giant SHEIN Buys Out Everlane for $100 Million](https://longbridge.com/en/news/286766131.md)
- [First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial](https://longbridge.com/en/news/286888745.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)